Evidence map›Paper›PMID 27621431›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

E4F1-mediated control of pyruvate dehydrogenase activity is essential for skin homeostasis.

Perrine Goguet-Rubio, Berfin Seyran, Laurie Gayte, Florence Bernex, Anne Sutter, Hélène Delpech, Laetitia Karine Linares, Romain Riscal, Cendrine Repond, Geneviève Rodier and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 2 countries.

Perrine Goguet-RubioInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France;
Berfin SeyranInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France;
Laurie GayteInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France;
Florence BernexInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Réseau d'Histologie Expérimentale de Montpellier, BioCampus, CNRS-UMS3426, F-34094 Montpellier, France;ORCID 0000-0003-0366-4315
Anne SutterInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France;
Hélène DelpechInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France; Institut de Génétique Moléculaire de Montpellier, CNRS-UMR5535, Montpellier 34293, France;
Laetitia Karine LinaresInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France;
Romain RiscalInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France;
Cendrine RepondDepartment of Physiology, University of Lausanne, 1005 Lausanne, Switzerland;
Geneviève RodierInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France; Institut de Génétique Moléculaire de Montpellier, CNRS-UMR5535, Montpellier 34293, France;
Olivier KirshInstitut de Génétique Moléculaire de Montpellier, CNRS-UMR5535, Montpellier 34293, France; Epigenetics and Cell Fate, University Paris Diderot, Sorbonne Paris Cite, UMR7216 CNRS, Paris 75013, France;ORCID 0000-0001-6200-5681
Jawida TouhamiUniversity of Montpellier, Montpellier F-34090, France; Institut de Génétique Moléculaire de Montpellier, CNRS-UMR5535, Montpellier 34293, France;
Jean NoelInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Réseau d'Histologie Expérimentale de Montpellier, BioCampus, CNRS-UMS3426, F-34094 Montpellier, France;
Charles VincentInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France;
Nelly PirotInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Réseau d'Histologie Expérimentale de Montpellier, BioCampus, CNRS-UMS3426, F-34094 Montpellier, France;
Guillaume PavlovicInstitut de la Clinique de la Souris-Mouse Clinical Institute, PHENOMIN, CNRS-UMR7104, INSERM U964, Université de Strasbourg, Illkirch, France.ORCID 0000-0001-9122-4592
Yann HeraultInstitut de la Clinique de la Souris-Mouse Clinical Institute, PHENOMIN, CNRS-UMR7104, INSERM U964, Université de Strasbourg, Illkirch, France.
Marc SitbonUniversity of Montpellier, Montpellier F-34090, France; Institut de Génétique Moléculaire de Montpellier, CNRS-UMR5535, Montpellier 34293, France;ORCID 0000-0003-3616-2338
Luc PellerinDepartment of Physiology, University of Lausanne, 1005 Lausanne, Switzerland;
Claude SardetInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France; Institut de Génétique Moléculaire de Montpellier, CNRS-UMR5535, Montpellier 34293, France;
Matthieu LacroixInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France; matthieu.lacroix@inserm.fr laurent.lecam@inserm.fr.
Laurent Le CamInstitut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France; INSERM U1194, Montpellier F-34298, France; University of Montpellier, Montpellier F-34090, France; Institut Régional du Cancer de Montpellier, Montpellier F-34298, France; Equipe labellisée Ligue Contre le Cancer, 75013 Paris, France; matthieu.lacroix@inserm.fr laurent.lecam@inserm.fr.
Inserm · FRCentre National de la Recherche Scientifique · FRUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The multifunctional protein E4 transcription factor 1 (E4F1) is an essential regulator of epidermal stem cell (ESC) maintenance. Here, we found that E4F1 transcriptionally regulates a metabolic program involved in pyruvate metabolism that is required to maintain skin homeostasis. E4F1 deficiency in basal keratinocytes resulted in deregulated expression of dihydrolipoamide acetyltransferase (Dlat), a gene encoding the E2 subunit of the mitochondrial pyruvate dehydrogenase (PDH) complex. Accordingly, E4f1 knock-out (KO) keratinocytes exhibited impaired PDH activity and a redirection of the glycolytic flux toward lactate production. The metabolic reprogramming of E4f1 KO keratinocytes associated with remodeling of their microenvironment and alterations of the basement membrane, led to ESC mislocalization and exhaustion of the ESC pool. ShRNA-mediated depletion of Dlat in primary keratinocytes recapitulated defects observed upon E4f1 inactivation, including increased lactate secretion, enhanced activity of extracellular matrix remodeling enzymes, and impaired clonogenic potential. Altogether, our data reveal a central role for Dlat in the metabolic program regulated by E4F1 in basal keratinocytes and illustrate the importance of PDH activity in skin homeostasis.

Indexed as

HomeostasisAnimalsAnimals, NewbornBasement MembraneCell AdhesionCells, CulturedCellular MicroenvironmentDihydrolipoyllysine-Residue AcetyltransferaseDNA-Binding ProteinsEpidermal CellsEpidermisGene Expression RegulationKeratinocytesMice, KnockoutMitochondrial ProteinsMonocarboxylic Acid TransportersDihydrolipoyllysine-Residue AcetyltransferaseDlat protein, mouseDNA-Binding ProteinsE4f1 protein, mouseMitochondrial ProteinsMonocarboxylic Acid TransportersMuscle ProteinsPyruvatesRepressor ProteinsRNA, MessengerSlc16a4 protein, mouseTranscription FactorsUbiquitin-Protein LigasesE4F1PDHpyruvateskinstem cell

Identifiers

PMID27621431
PMCPMC5047149
OpenAlexW2520818180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.